Neutron Therapeutics, Inc.
Neutron Therapeutics is the leading provider of Boron Neutron Capture Therapy (BNCT) systems for targeted radiation therapy of solid tumors. Neutron Therapeutics' flagship product, the nuBeam® suite, is an accelerator-based, in-hospital neutron source designed to replace nuclear reactors in BNCT. nuBeam® has the highest flux of all commercially available BNCT systems, offering significantly shorter treatment times for patients, and is the only BNCT device compliant with IAEA standards for the clinical use of neutrons. (The nuBeam® suite is an investigational product and has not been approved by the FDA or PMDA.)